prednisolone has been researched along with Extramembranous Glomerulopathy in 131 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Combined treatment with cyclosporine microemulsion preconcentrate (CyA MEPC) and steroids has been widely used for idiopathic membranous nephropathy (IMN) associated with steroid-resistant nephrotic syndrome (SRNS)." | 9.19 | Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial. ( Imai, E; Iwano, M; Kataoka, Y; Koyama, A; Maruyama, S; Matsumoto, K; Matsuo, S; Mitarai, T; Nangaku, M; Nishi, S; Ogahara, S; Saito, T; Sato, H; Shuto, H; Tomino, Y; Ueda, S; Yokoyama, H; Yorioka, N; Yoshimura, A, 2014) |
| "A prospective, randomized, controlled, open-label study was performed to investigate the efficacy and tolerability of MMF and prednisolone as primary treatment in MN with nephrotic syndrome." | 9.12 | Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome. ( Chan, KW; Chan, TM; Ho, YW; Lai, KN; Lam, MF; Lin, AW; Qian, JQ; Tang, CS; Tang, SC; Tse, KC, 2007) |
| " We examined outcomes of a short course of cyclophosphamide alternating with prednisolone for MN patients with nephrotic syndrome." | 7.72 | Nephrotic syndrome caused by membranous nephropathy: response to a short course of cyclophosphamide alternating with prednisolone. ( Eto, T; Fujimoto, S; Hara, S; Hisanaga, S; Sato, Y; Yamada, K, 2004) |
| "During long-term treatment relapses were more frequent in the monotherapy group (47 vs 15%, P<0." | 6.72 | Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. ( Alexopoulos, E; Leontsini, M; Memmos, D; Papagianni, A; Tsamelashvili, M, 2006) |
| "Progressive passive Heymann nephritis (group II) was induced in rats by i." | 5.28 | Accelerated passive Heymann nephritis in rats as an experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis. ( Aono, Y; Ito, M; Nagamatsu, T; Suzuki, A; Suzuki, Y, 1989) |
| "Combined treatment with cyclosporine microemulsion preconcentrate (CyA MEPC) and steroids has been widely used for idiopathic membranous nephropathy (IMN) associated with steroid-resistant nephrotic syndrome (SRNS)." | 5.19 | Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial. ( Imai, E; Iwano, M; Kataoka, Y; Koyama, A; Maruyama, S; Matsumoto, K; Matsuo, S; Mitarai, T; Nangaku, M; Nishi, S; Ogahara, S; Saito, T; Sato, H; Shuto, H; Tomino, Y; Ueda, S; Yokoyama, H; Yorioka, N; Yoshimura, A, 2014) |
| "Low doses of CsA with prednisolone induce remission of nephrotic syndrome in most idiopathic membranous nephropathy patients." | 5.14 | Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy. ( Goumenos, DS; Kalliakmani, P; Koutroulia, E; Sotsiou, F; Vlachojannis, JG, 2010) |
| "A prospective, randomized, controlled, open-label study was performed to investigate the efficacy and tolerability of MMF and prednisolone as primary treatment in MN with nephrotic syndrome." | 5.12 | Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome. ( Chan, KW; Chan, TM; Ho, YW; Lai, KN; Lam, MF; Lin, AW; Qian, JQ; Tang, CS; Tang, SC; Tse, KC, 2007) |
| "Sixteen patients, with nephrotic syndrome due to IMN and well-preserved renal function, were treated with prednisolone (starting dose: 0." | 5.11 | The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. ( Goumenos, DS; Kalliakmani, P; Sotsiou, F; Tsakas, S; Vlachojannis, JG, 2004) |
| "A 49-year-old woman with membranous nephropathy was referred to our hospital during the tapering of oral prednisolone, because of suspicion of primary adrenal insufficiency based on a plasma ACTH level of 399." | 3.91 | Falsely elevated plasma ACTH levels measured by the Elecsys assay related to heterophilic antibody in a case of secondary adrenocortical insufficiency. ( Edo, N; Ishikawa, T; Kimura, M; Morita, K; Ogawa, M; Okawa, Y; Oki, Y; Tsukamoto, K, 2019) |
| " She responded to intensive immunosuppressive therapy consisting of prednisolone, tacrolimus, and MTX with a parallel reduction of proteinuria." | 3.91 | Membranous nephropathy caused by rheumatoid arthritis. ( Hayashi, J; Honda, K; Iida, A; Inaba, T; Iyoda, M; Shibata, T; Tachibana, S; Wada, Y, 2019) |
| "Intravenous cyclophosphamide therapy associated with oral prednisolone proved effective in inducing complete remission of nephrotic syndrome." | 3.73 | Systemic lupus erythematosus (SLE) presenting with nephrotic syndrome and membranous glomerulopathy in a 10-year-old girl. ( Afonso, C; Brito, I; Machado, V; Pontes, T, 2005) |
| " We examined outcomes of a short course of cyclophosphamide alternating with prednisolone for MN patients with nephrotic syndrome." | 3.72 | Nephrotic syndrome caused by membranous nephropathy: response to a short course of cyclophosphamide alternating with prednisolone. ( Eto, T; Fujimoto, S; Hara, S; Hisanaga, S; Sato, Y; Yamada, K, 2004) |
| " The effect of treatment with prednisolone and azathioprine in patients with nephrotic-range proteinuria and biopsy-proven IMN from a single center (Sheffield Kidney Institute, Sheffield, UK) is described." | 3.70 | Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy? ( Ahuja, M; Brown, CB; Gerakis, A; Goumenos, D; Shortland, JR, 1999) |
| "Twenty-one patients with membranous nephropathy, heavy proteinuria and progressive renal failure were treated with alternating monthly cycles of corticosteroids and chlorambucil for six months." | 3.69 | Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure. ( Boulton-Jones, JM; Geddes, CG; Warwick, GL, 1994) |
| " This occurred during an exacerbation of graft-versus-host disease (GVHD) and both problems remitted after therapy with cyclosporine and prednisolone." | 3.68 | Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. ( Barbara, JA; Gillis, D; Ho, JO; Smith, PS; Thomas, AC; Woodroffe, AJ, 1992) |
| "Idiopathic membranous nephropathy (IMN) is increasingly seen in older patients." | 2.79 | Patient age and the prognosis of idiopathic membranous nephropathy. ( Akiyama, S; Ando, M; Ito, Y; Kato, S; Katsuno, T; Kosugi, T; Maruyama, S; Matsuo, S; Mizuno, M; Sato, W; Tsuboi, N; Yamaguchi, M; Yamamoto, R; Yasuda, Y, 2014) |
| "For the subset of patients with idiopathic membranous nephropathy and deteriorating excretory renal function, 6 months' therapy with prednisolone and chlorambucil is the treatment approach best supported by our evidence." | 2.78 | Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial. ( Adu, D; Boulton-Jones, M; Chapman, TL; Feehally, J; Ferguson, C; Gaskin, GJ; Howman, A; Jayne, DR; Langdon, MM; Mathieson, PW; O'Donoghue, D, 2013) |
| " Retreatment with an augmented dosage of prednisolone, +/- another immunosuppressive agent, resulted in CR and PR in 15 (79%) and 4 (21%) of these flare episodes, respectively." | 2.74 | Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine. ( Mok, CC; Ng, WL; Wong, WS; Yim, CW; Ying, KY, 2009) |
| "In conclusion, untreated IMN with nephrotic syndrome is associated with a high risk for deterioration of renal function." | 2.73 | A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. ( Ganguli, A; Gupta, KL; Jha, V; Joshi, K; Kohli, HS; Saha, TK; Sakhuja, V; Sud, K, 2007) |
| "The prednisolone dose was gradually tapered, then discontinued." | 2.72 | Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature. ( Dohi, K; Fujimoto, M; Hirabayashi, Y; Katayama, K; Murata, T; Nakajima, A; Oda, K; Saiki, R, 2021) |
| "During long-term treatment relapses were more frequent in the monotherapy group (47 vs 15%, P<0." | 2.72 | Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. ( Alexopoulos, E; Leontsini, M; Memmos, D; Papagianni, A; Tsamelashvili, M, 2006) |
| "Appropriate treatment of idiopathic membranous nephropathy (IMN) remains a controversial issue." | 2.71 | [Clinical outcome assessment of membranous nephropathy]. ( Kumagai, T; Mise, N; Nishi, T; Shimizu, H; Sugimoto, T; Tagawa, H, 2005) |
| "Proteinuria has significantly reduced in 10 patients, and only four patients still have nephrotic-range proteinuria." | 2.69 | Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone. ( Brown, JH; Doherty, CC; Douglas, AF; Hill, CM; McNamee, PT; Murphy, BG; Nelson, WE, 1998) |
| "In idiopathic membranous nephropathy (IMN) immunosuppressive therapy should be reserved for patients with potential risk factors at baseline or who show a progressive course." | 2.67 | Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy. ( Kibriya, MG; Nikolov, D; Tishkov, I, 1994) |
| "Chlorambucil was given during months 2, 4, and 6 at a dose of 0." | 2.67 | Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis. ( Brunkhorst, R; Koch, KM; Wrenger, E, 1994) |
| "Patients of idiopathic membranous nephropathy (MGN) were randomly assigned to received steroid and cyclophosphamide every other month (Gr-I) and steroid alone (Gr-II)." | 2.67 | Prognosis and management of membraneous nephropathy. ( Banerjee, D; Das, S; Dutta, BN; Pahari, DK, 1993) |
| "Renal biopsy demonstrated secondary membranous nephropathy (MN) with mild mesangial proliferation and some electron-dense deposits in the mesangium." | 2.46 | Membranous nephropathy and Kimura's disease manifesting a hip mass. A case report with literature review. ( Furusu, A; Ichinose, H; Iwasaki, K; Kohno, S; Nishino, T; Obata, Y; Ohnita, A; Taguchi, T, 2010) |
| "Persistent proteinuria is not only a marker of irreversible glomerular lesions but also a risk factor for tubulointerstitial lesions, which plays a significant role in progression into ESRD." | 2.42 | [Refractory nephrotic syndrome]. ( Saito, T, 2004) |
| "Renal biopsy demonstrated membranous nephropathy in Case 1 and minimal-change lesion in Case 2." | 2.38 | Long-term effects of steroid treatment on nephrotic syndrome associated with Kimura's disease and a review of the literature. ( Chida, Y; Hiruma, M; Ida, T; Ishibashi, K; Makiguchi, K; Marumo, F; Matsuda, K; Matsuda, O; Tomita, K, 1992) |
| " Very long-term use of cyclophosphamide, in excess of 12 months, is probably associated with unacceptable long-term risks, particularly the emergence of neoplasia." | 2.38 | The therapy of idiopathic membranous glomerulonephritis. ( Glassock, RJ, 1991) |
| "Pathological examination revealed membranous nephropathy with IgG deposits on both the glomerular basement membrane (GBM) and the tubular basement membrane (TBM)." | 1.91 | An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous nephropathy. ( Hara, S; Nozu, K; Tanaka, Y; Yamamoto, M, 2023) |
| "Treatment with prednisolone (PSL) reduced urinary protein from 7." | 1.91 | Complete remission of primary membranous nephropathy following hepatitis E infection. ( Igarashi, H; Kitayama, Y; Koyano, A; Rachi, H; Shimasaki, M; Shiratori, K; Sugiura, T; Takanohashi, S; Togawa, A; Ueno, T, 2023) |
| "Membranous nephropathy is a rare manifestation of IgG4-related kidney disease." | 1.48 | A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis. ( Akiyama, S; Arai, H; Endo, S; Kamimatsuse, R; Maruyama, S; Matsubara, T; Nishioka, K; Toda, N; Yanagita, M; Yokoi, H, 2018) |
| "Idiopathic membranous nephropathy (IMN) is one of the most common causes of nephrotic syndrome (NS) in Caucasian adults." | 1.48 | Outcome of Idiopathic Membranous Nephropathy: A Retrospective Study. ( Benchetrit, S; Kotliroff, A; Rozenberg, I; Zahavi, T, 2018) |
| "Membranous nephropathy is a common cause of nephrotic syndrome in adults." | 1.40 | Membranous nephropathy with crescents in a patient with Hashimoto's thyroiditis: a case report. ( Bracamonte, E; John, SG; Ossai, NO; Riaz, IB; Sussman, AN; Thajudeen, B, 2014) |
| "Membranous nephropathy was diagnosed." | 1.39 | De novo postallogeneic hematopoietic stem cell transplant membranous nephropathy. ( Ando, Y; Kusano, E; Mori, M; Morishita, Y; Muto, S; Numata, A; Saito, O; Takemoto, F; Yumura, W, 2013) |
| "Kaposi sarcoma is a malignant vascular neoplasm uncommonly seen in immunosuppressed patients." | 1.39 | Tonsillar Kaposi sarcoma in a patient with membranous glomerulonephritis on immunosuppressive therapy. ( Ahmad, MS; Al-Brahim, N; El-Merhi, K; Zaki, AH, 2013) |
| " An ARB was given to all patients and the same dosage was used throughout the study." | 1.37 | Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy. ( Esaki, S; Gondo, A; Hayashi, A; Matsumoto, H; Miyaoka, Y; Nagaoka, Y; Nakao, T; Okada, T; Wada, T, 2011) |
| "We experienced a rare case of membranous glomerulopathy(MN) with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis." | 1.37 | [Case of MPO-ANCA-associated vasculitis with membranous nephropathy]. ( Arimura, Y; Kaname, S; Kawashima, S; Nomura, K; Watanabe, S; Yamada, A; Yoshihara, K, 2011) |
| "Membranous nephropathy is uncommon in Chinese children and could be a possible early presentation of SLE." | 1.36 | An unusual case of loin pain and nephritis. ( Chiu, MC; Lai, WM; Ma, AL, 2010) |
| " Patients were treated with cyclophosphamide (50 mg/day for the first 3 months and 25 mg/day for the next 3 months) and prednisolone (30 mg/day for the first week and the dosage was gradually tapered to withdraw by 2 years)." | 1.35 | Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. ( Eriguchi, M; Harada, A; Kamimura, T; Mizobuchi, T; Oka, H; Sugawara, K, 2009) |
| "A 9-year-old boy diagnosed as having Rasmussen syndrome had congenital IgA deficiency and juvenile alopecia." | 1.35 | Rasmussen syndrome combined with IgA deficiency and membranous nephropathy. ( Ichikawa, K; Ito, S; Nezu, A; Takeshita, S, 2009) |
| "Two were complicated with primary biliary cirrhosis (PBC) and autoimmune thyroiditis, whereas the other was complicated with interstitial pneumonia, but not with either PBC or autoimmune thyroiditis." | 1.33 | [Three patients with nephrotic syndrome due to membranous nephropathy complicated by Sjögren's syndrome]. ( Baba, A; Eto, T; Fujimoto, S; Hara, S; Sato, Y; Yamada, K, 2005) |
| "Idiopathic membranous nephropathy (IMN) is the most common cause of nephrotic syndrome in adults." | 1.33 | Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study. ( Ahuja, M; Brown, CB; Davlouros, P; El Nahas, AM; Goumenos, DS, 2006) |
| "In patients with idiopathic membranous nephropathy and renal insufficiency, treatment with cyclophosphamide and steroids resulted in an improvement of glomerular permeability and tubular proteinuria." | 1.33 | Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency. ( du Buf-Vereijken, PW; Wetzels, JF, 2006) |
| " Initial dosage prednisolone was given for 1 month, and then tapered gradually in terms of dosage and interval." | 1.32 | [Quadritherapy with cyclosporine for membranous lupus nephropathy]. ( Iwasawa, H; Matsumoto, H; Nagaoka, Y; Nakao, T; Okada, T; Tomaru, R; Wada, T, 2003) |
| "He was diagnosed as having membranous nephropathy by renal biopsy and was treated with prednisolone." | 1.31 | Membranoproliferative glomerulonephritis associated with hypocomplementemic urticarial vasculitis after complete remission of membranous nephropathy. ( Arakawa, M; Gejou, F; Imai, N; Miyamura, S; Nishi, S; Saeki, T; Shimada, H; Ueno, M, 2001) |
| "The renal biopsy findings indicated membranous nephropathy." | 1.31 | [An elderly case of ANCA-positive membranous nephropathy]. ( Honda, K; Kawashima, A; Nihei, H; Nitta, K; Onuki, T; Sekine, S; Suganuma, S; Tanaka, Y; Uchida, K; Yumura, W, 2002) |
| "Prednisolone was administered at the dose of 30 mg/day for 4 weeks and tapered subsequently." | 1.30 | [A case of hepatitis C virus associated membranous glomerulonephritis ameliorated by corticosteroid therapy]. ( Ito, S; Kurihara, I; Nakayama, K; Saito, T; Sato, H; Soma, J; Yusa, A, 1998) |
| " No untoward effect from drugs sufficient to alter the dosage used was recorded." | 1.30 | Clinical features and treatment outcome of idiopathic membranous nephropathy in Chinese patients. ( Chan, TM; Cheng, IK; Lai, KN; Tang, S, 1999) |
| "The risk of membranous nephropathy was 35 and 15 times higher in the 178 African children with nephrotic syndrome who had serological evidence of HBsAg and HBeAg, respectively, than in those who did not." | 1.29 | Hepatitis B 's' and 'e' antigen carriage in childhood nephrotic syndrome predicts membranous glomerulonephritis. ( Adhikari, M; Coovadia, HM; Moodley, D, 1993) |
| "Thirty-six patients with idiopathic membranous nephropathy were retrospectively studied." | 1.29 | Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy. ( Alexopoulos, E; Karamitsos, K; Leontsini, M; Memmos, D; Papadimitriou, M; Sakellariou, G, 1993) |
| "Membranous nephropathy has been described in association with many malignancies including various lymphomas." | 1.29 | Membranous nephropathy complicating adenolymphoma of the parotid (Warthin's tumour). ( Dodd, SM; Fan, SL; Kon, SP; Kwan, JT; Raftery, MJ, 1996) |
| "Sixty-five patients with primary membranous nephropathy were examined in order to assess the effects of long-term treatment with corticosteroid." | 1.28 | Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid. ( Funabiki, K; Koide, H; Shirato, I; Tomino, Y; Yoshida, M, 1992) |
| "prednisolone (PSL) treated nephrotic stage, 3." | 1.28 | Two-color analysis of lymphocyte subpopulations in patients with nephrotic syndrome due to membranous nephropathy. ( Koide, H; Nakayama, S; Ozaki, T; Tomino, Y, 1992) |
| "Progressive passive Heymann nephritis (group II) was induced in rats by i." | 1.28 | Accelerated passive Heymann nephritis in rats as an experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis. ( Aono, Y; Ito, M; Nagamatsu, T; Suzuki, A; Suzuki, Y, 1989) |
| "Eight patients with idiopathic membranous nephropathy whose renal function was deteriorating were given a 6-month course of alternating monthly cycles of prednisolone and chlorambucil." | 1.27 | Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function. ( Evans, DJ; Maidment, CG; Mathieson, PW; Rees, AJ; Turner, AN, 1988) |
| "Between 1973 and 1986, 109 patients with membranous nephropathy have been evaluated with respect to clinical presentation, pathological features and factors determining prognosis." | 1.27 | The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy. ( Aarons, I; Clarkson, AR; Shearman, JD; Smith, PS; Woodroffe, AJ; Yin, ZG, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (6.11) | 18.7374 |
| 1990's | 40 (30.53) | 18.2507 |
| 2000's | 36 (27.48) | 29.6817 |
| 2010's | 40 (30.53) | 24.3611 |
| 2020's | 7 (5.34) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, Y | 3 |
| Yamamoto, M | 2 |
| Nozu, K | 2 |
| Hara, S | 6 |
| Takanohashi, S | 1 |
| Sugiura, T | 1 |
| Koyano, A | 1 |
| Ueno, T | 1 |
| Rachi, H | 1 |
| Shiratori, K | 1 |
| Shimasaki, M | 1 |
| Igarashi, H | 1 |
| Kitayama, Y | 1 |
| Togawa, A | 1 |
| Nakagawa, N | 1 |
| Kimura, T | 1 |
| Sakate, R | 1 |
| Wada, T | 4 |
| Furuichi, K | 1 |
| Okada, H | 1 |
| Isaka, Y | 2 |
| Narita, I | 2 |
| Onozato, Y | 1 |
| Sasaki, Y | 1 |
| Abe, Y | 1 |
| Yaoita, T | 1 |
| Yagi, M | 1 |
| Mizumoto, N | 1 |
| Shoji, M | 1 |
| Kon, T | 1 |
| Sakai, T | 2 |
| Ueno, Y | 1 |
| Peng, J | 1 |
| Cao, L | 1 |
| Saiki, R | 1 |
| Katayama, K | 1 |
| Hirabayashi, Y | 1 |
| Oda, K | 1 |
| Fujimoto, M | 1 |
| Murata, T | 1 |
| Nakajima, A | 1 |
| Dohi, K | 1 |
| Nishizawa, K | 1 |
| Yamashita, T | 1 |
| Ogawa, Y | 1 |
| Kobayashi, H | 1 |
| Yu, X | 1 |
| Ruan, L | 1 |
| Qu, Z | 1 |
| Cui, Z | 1 |
| Zhang, Y | 2 |
| Wang, X | 1 |
| Meng, L | 1 |
| Liu, X | 1 |
| Wang, F | 1 |
| Liu, G | 1 |
| Yang, L | 1 |
| Rozenberg, I | 1 |
| Kotliroff, A | 1 |
| Zahavi, T | 1 |
| Benchetrit, S | 1 |
| Arai, H | 1 |
| Toda, N | 1 |
| Kamimatsuse, R | 1 |
| Nishioka, K | 1 |
| Endo, S | 1 |
| Akiyama, S | 3 |
| Maruyama, S | 5 |
| Matsubara, T | 1 |
| Yokoi, H | 1 |
| Yanagita, M | 1 |
| Yamaguchi, M | 2 |
| Ando, M | 2 |
| Katsuno, T | 2 |
| Tsuboi, N | 2 |
| Matsumoto, A | 1 |
| Matsui, I | 1 |
| Namba, T | 1 |
| Sakaguchi, Y | 1 |
| Mizuno, H | 1 |
| Shirayama, Y | 1 |
| Shimada, K | 1 |
| Hashimoto, N | 1 |
| Doi, Y | 1 |
| Yamaguchi, S | 1 |
| Kubota, K | 1 |
| Oka, T | 2 |
| Mori, D | 1 |
| Hamano, T | 1 |
| Mizui, M | 1 |
| Takabatake, Y | 1 |
| Kaneko, T | 1 |
| Morita, K | 1 |
| Ogawa, M | 1 |
| Kimura, M | 2 |
| Okawa, Y | 1 |
| Oki, Y | 1 |
| Edo, N | 1 |
| Tsukamoto, K | 1 |
| Ishikawa, T | 1 |
| Iida, A | 1 |
| Wada, Y | 1 |
| Hayashi, J | 1 |
| Tachibana, S | 1 |
| Inaba, T | 1 |
| Iyoda, M | 1 |
| Honda, K | 2 |
| Shibata, T | 1 |
| Remuzzi, G | 2 |
| Ruggenenti, P | 2 |
| Gödel, M | 1 |
| Huber, TB | 1 |
| Cirillo, M | 1 |
| Dhaun, N | 1 |
| Kluth, DC | 1 |
| Chen, Z | 1 |
| Du, X | 1 |
| Hofstra, J | 1 |
| Wetzels, J | 1 |
| Mathieson, PW | 3 |
| Al-Brahim, N | 1 |
| Zaki, AH | 1 |
| El-Merhi, K | 1 |
| Ahmad, MS | 1 |
| Saito, T | 6 |
| Iwano, M | 1 |
| Matsumoto, K | 1 |
| Mitarai, T | 2 |
| Yokoyama, H | 4 |
| Yorioka, N | 3 |
| Nishi, S | 3 |
| Yoshimura, A | 2 |
| Sato, H | 3 |
| Ogahara, S | 1 |
| Shuto, H | 1 |
| Kataoka, Y | 1 |
| Ueda, S | 1 |
| Koyama, A | 2 |
| Nangaku, M | 1 |
| Imai, E | 1 |
| Matsuo, S | 3 |
| Tomino, Y | 3 |
| Thajudeen, B | 1 |
| John, SG | 1 |
| Ossai, NO | 1 |
| Riaz, IB | 1 |
| Bracamonte, E | 1 |
| Sussman, AN | 1 |
| Sugiyama, H | 2 |
| Yamagata, K | 2 |
| Nishio, S | 1 |
| Fujimoto, S | 4 |
| Mori, N | 1 |
| Yuzawa, Y | 3 |
| Okuda, S | 2 |
| Ueda, Y | 2 |
| Makino, H | 3 |
| Ito, T | 2 |
| Mochizuki, K | 1 |
| Hanada, K | 1 |
| Tanabe, K | 1 |
| Yamamoto, R | 1 |
| Kato, S | 2 |
| Kosugi, T | 1 |
| Sato, W | 2 |
| Yasuda, Y | 1 |
| Mizuno, M | 1 |
| Ito, Y | 1 |
| Müller-Deile, J | 1 |
| Schiffer, L | 1 |
| Hiss, M | 1 |
| Haller, H | 1 |
| Schiffer, M | 1 |
| Doke, T | 1 |
| Takahashi, K | 1 |
| Hayashi, H | 1 |
| Koide, S | 1 |
| Sasaki, H | 1 |
| Kusaka, M | 1 |
| Shiroki, R | 1 |
| Hoshinaga, K | 1 |
| Takeda, A | 1 |
| Hasegawa, M | 2 |
| Ramachandran, R | 1 |
| Kumar, V | 1 |
| Jha, V | 3 |
| Weng, Q | 1 |
| Li, X | 1 |
| Ren, H | 1 |
| Xie, J | 1 |
| Pan, X | 1 |
| Xu, J | 1 |
| Chen, N | 1 |
| Prasad, KP | 1 |
| Alahakoon, DG | 1 |
| Vidanagama, U | 1 |
| Ichikawa, K | 1 |
| Takeshita, S | 1 |
| Ito, S | 2 |
| Nezu, A | 1 |
| Eriguchi, M | 1 |
| Oka, H | 1 |
| Mizobuchi, T | 1 |
| Kamimura, T | 1 |
| Sugawara, K | 1 |
| Harada, A | 1 |
| Mok, CC | 1 |
| Ying, KY | 1 |
| Yim, CW | 1 |
| Ng, WL | 1 |
| Wong, WS | 1 |
| Ma, AL | 1 |
| Lai, WM | 1 |
| Chiu, MC | 1 |
| Obata, Y | 1 |
| Furusu, A | 1 |
| Nishino, T | 1 |
| Ichinose, H | 1 |
| Ohnita, A | 1 |
| Iwasaki, K | 1 |
| Taguchi, T | 2 |
| Kohno, S | 2 |
| Nabeshima, K | 1 |
| Akimoto, T | 2 |
| Otake, T | 1 |
| Tanaka, A | 1 |
| Takahashi, H | 1 |
| Higashizawa, T | 1 |
| Inoue, M | 1 |
| Nishino, K | 1 |
| Saito, O | 3 |
| Isoda, N | 1 |
| Muto, S | 3 |
| Sugano, K | 1 |
| Kusano, E | 3 |
| Kalliakmani, P | 3 |
| Koutroulia, E | 1 |
| Sotsiou, F | 2 |
| Vlachojannis, JG | 2 |
| Goumenos, DS | 4 |
| Watanabe, S | 1 |
| Arimura, Y | 1 |
| Nomura, K | 1 |
| Kawashima, S | 1 |
| Yoshihara, K | 1 |
| Kaname, S | 1 |
| Yamada, A | 1 |
| Numata, A | 2 |
| Toshima, M | 1 |
| Iwazu, Y | 1 |
| Otani, N | 1 |
| Miki, T | 1 |
| Sugase, T | 1 |
| Hamano, Y | 1 |
| Takemoto, F | 3 |
| Matsumoto, H | 2 |
| Nagaoka, Y | 2 |
| Okada, T | 2 |
| Gondo, A | 1 |
| Esaki, S | 1 |
| Hayashi, A | 1 |
| Miyaoka, Y | 1 |
| Nakao, T | 2 |
| Usui, J | 1 |
| Hirayama, K | 1 |
| Suzuki, S | 1 |
| Morishita, Y | 1 |
| Mori, M | 1 |
| Ando, Y | 1 |
| Yumura, W | 3 |
| Papasotiriou, M | 1 |
| Huang, L | 1 |
| Gerolymos, M | 1 |
| Johnson, TS | 1 |
| Howman, A | 1 |
| Chapman, TL | 1 |
| Langdon, MM | 1 |
| Ferguson, C | 1 |
| Adu, D | 2 |
| Feehally, J | 1 |
| Gaskin, GJ | 1 |
| Jayne, DR | 1 |
| O'Donoghue, D | 1 |
| Boulton-Jones, M | 1 |
| Ikeda, K | 1 |
| Okamoto, T | 1 |
| Yamamura, T | 1 |
| Ohsawa, I | 2 |
| Furutera, R | 1 |
| Murata, M | 1 |
| Sakai, H | 1 |
| Kurokawa, K | 2 |
| Shiiki, H | 1 |
| Tomaru, R | 1 |
| Iwasawa, H | 1 |
| Tsakas, S | 1 |
| Sato, Y | 2 |
| Yamada, K | 2 |
| Hisanaga, S | 2 |
| Eto, T | 2 |
| Pape, L | 1 |
| Mengel, M | 1 |
| Offner, G | 1 |
| Ehrich, JH | 1 |
| Stevenson, WS | 1 |
| Nankivell, BJ | 1 |
| Hertzberg, MS | 1 |
| Hoshino, J | 1 |
| Ubara, Y | 1 |
| Takaya, H | 1 |
| Suwabe, T | 1 |
| Sawa, N | 1 |
| Tagami, T | 1 |
| Katori, H | 1 |
| Takaichi, K | 1 |
| Hasegawa, O | 1 |
| Honda, M | 1 |
| Ikeda, M | 1 |
| Ece, A | 1 |
| Bosnak, M | 1 |
| Gurkan, F | 1 |
| Davutoglu, M | 1 |
| Haspolat, K | 1 |
| Imai, H | 2 |
| du Buf-Vereijken, PW | 1 |
| Wetzels, JF | 1 |
| Machado, V | 1 |
| Pontes, T | 1 |
| Brito, I | 1 |
| Afonso, C | 1 |
| Hall, AM | 1 |
| Symington, EM | 1 |
| Sampson, SA | 1 |
| Kwan, JT | 3 |
| Matsuo, T | 1 |
| Mori, Y | 1 |
| Hashimoto, T | 1 |
| Tajima, M | 1 |
| Okado, T | 1 |
| Tsukamoto, Y | 1 |
| Kobayashi, Y | 2 |
| Sasaki, S | 2 |
| Kumagai, T | 1 |
| Shimizu, H | 1 |
| Nishi, T | 1 |
| Mise, N | 1 |
| Tagawa, H | 1 |
| Sugimoto, T | 1 |
| Baba, A | 1 |
| Nishioka, Y | 1 |
| Horita, Y | 1 |
| Tadokoro, M | 1 |
| Taura, K | 1 |
| Suyama, N | 1 |
| Miyazaki, M | 1 |
| Harada, T | 1 |
| Ahuja, M | 2 |
| Davlouros, P | 1 |
| El Nahas, AM | 1 |
| Brown, CB | 2 |
| Alexopoulos, E | 3 |
| Papagianni, A | 1 |
| Tsamelashvili, M | 1 |
| Leontsini, M | 3 |
| Memmos, D | 2 |
| Asaka, M | 1 |
| Yamaya, H | 1 |
| Ganguli, A | 2 |
| Saha, TK | 1 |
| Kohli, HS | 2 |
| Sud, K | 1 |
| Gupta, KL | 2 |
| Joshi, K | 2 |
| Sakhuja, V | 2 |
| Senthil Nayagam, L | 1 |
| Rathi, M | 1 |
| Chan, TM | 2 |
| Lin, AW | 1 |
| Tang, SC | 1 |
| Qian, JQ | 1 |
| Lam, MF | 1 |
| Ho, YW | 1 |
| Tse, KC | 1 |
| Chan, KW | 1 |
| Lai, KN | 2 |
| Tang, CS | 1 |
| Yoshimura, J | 1 |
| Tamaki, K | 1 |
| Kohno, K | 1 |
| Kaneyuki, U | 1 |
| Maeda, M | 1 |
| Saikusa-Itoh, Y | 1 |
| Hayashida, A | 1 |
| Iida, S | 1 |
| Suefuji, H | 1 |
| Ikegaya, N | 1 |
| Nagase, M | 1 |
| Honda, N | 2 |
| Kumagai, H | 1 |
| Hishida, A | 2 |
| Coovadia, HM | 1 |
| Adhikari, M | 1 |
| Moodley, D | 1 |
| Sanderson, F | 1 |
| Fervenza, F | 1 |
| Winearls, CG | 1 |
| Baker, LR | 3 |
| Tucker, B | 3 |
| Macdougall, IC | 3 |
| Raine, AE | 1 |
| Kaji, T | 1 |
| Tsukada, Y | 2 |
| Shimada, A | 1 |
| Miyamoto, K | 1 |
| Yoshida, M | 2 |
| Yano, S | 2 |
| Naruse, T | 2 |
| Papadimitriou, M | 2 |
| Pahari, DK | 1 |
| Das, S | 1 |
| Dutta, BN | 1 |
| Banerjee, D | 1 |
| Brunkhorst, R | 1 |
| Wrenger, E | 1 |
| Koch, KM | 1 |
| Kibriya, MG | 1 |
| Tishkov, I | 1 |
| Nikolov, D | 1 |
| Warwick, GL | 1 |
| Geddes, CG | 1 |
| Boulton-Jones, JM | 1 |
| Johnston, PA | 1 |
| Goode, NP | 1 |
| Aparicio, SR | 1 |
| Davison, AM | 1 |
| Sakellariou, G | 1 |
| Karamitsos, K | 1 |
| Yoshida, H | 1 |
| Takano, T | 1 |
| Tsujino, S | 1 |
| Higashihara, M | 1 |
| Nozaka, K | 1 |
| Kaneko, Y | 1 |
| Watanabe, T | 1 |
| Sakemi, T | 1 |
| Hayashida, R | 1 |
| Ikeda, Y | 1 |
| Baba, N | 1 |
| Nishihara, G | 1 |
| Kohda, H | 1 |
| Crowe, AV | 1 |
| Raman, GV | 1 |
| Turner, AM | 1 |
| Kon, SP | 1 |
| Fan, SL | 1 |
| Dodd, SM | 2 |
| Raftery, MJ | 1 |
| Tanaka, T | 1 |
| Kitahara, T | 1 |
| Takagi, C | 1 |
| Kuroiwa, T | 1 |
| Shigehara, T | 1 |
| Hiromura, K | 1 |
| Ueki, K | 1 |
| Kanai, H | 1 |
| Maezawa, A | 1 |
| Oommen, R | 2 |
| Brown, JH | 1 |
| Douglas, AF | 1 |
| Murphy, BG | 1 |
| Hill, CM | 1 |
| McNamee, PT | 1 |
| Nelson, WE | 1 |
| Doherty, CC | 1 |
| Kurihara, I | 1 |
| Nakayama, K | 1 |
| Yusa, A | 1 |
| Soma, J | 1 |
| Endo, M | 1 |
| Ohi, H | 1 |
| Fujita, T | 1 |
| Kanmatsuse, K | 1 |
| Yamaguchi, Y | 1 |
| Yamaji, H | 1 |
| Shikata, K | 1 |
| Wada, J | 1 |
| Hayashi, Y | 1 |
| Ikeda, S | 1 |
| Goto, T | 1 |
| Komatsu, M | 1 |
| Fujii, T | 1 |
| Ohshima, S | 1 |
| Nakane, K | 1 |
| Yoneyama, K | 1 |
| Shibuya, T | 1 |
| Meng, XW | 1 |
| Masamune, O | 1 |
| Tamura, K | 1 |
| Takagi, N | 1 |
| Yabana, M | 1 |
| Kihara, M | 1 |
| Toya, Y | 1 |
| Takizawa, T | 1 |
| Takeshita, Y | 1 |
| Tokita, Y | 1 |
| Inayama, Y | 1 |
| Umemura, S | 1 |
| Tsuji, Y | 1 |
| Mizuno, Y | 1 |
| Iikura, Y | 1 |
| Goumenos, D | 1 |
| Shortland, JR | 1 |
| Gerakis, A | 1 |
| Taniguchi, Y | 1 |
| Kumagai, J | 1 |
| Yamakido, M | 1 |
| Polenakovik, MH | 1 |
| Grcevska, L | 1 |
| Toda, T | 1 |
| Kimoto, S | 1 |
| Nishio, Y | 1 |
| Ehara, T | 1 |
| Tang, S | 1 |
| Cheng, IK | 1 |
| Sano, T | 1 |
| Kamata, K | 1 |
| Shigematsu, H | 1 |
| Taskapan, H | 1 |
| Oymak, O | 1 |
| Dogukan, A | 1 |
| Ozbakir, O | 1 |
| Utas, C | 1 |
| Saeki, T | 1 |
| Ueno, M | 1 |
| Shimada, H | 1 |
| Imai, N | 1 |
| Miyamura, S | 1 |
| Gejou, F | 1 |
| Arakawa, M | 1 |
| Heering, P | 1 |
| Schneider, A | 1 |
| Grabensee, B | 1 |
| Plum, J | 1 |
| Shirota, S | 1 |
| Tsuchiya, K | 1 |
| Takada, M | 1 |
| Komeda, M | 1 |
| Oomae, K | 1 |
| Ogawa, T | 1 |
| Nitta, K | 2 |
| Nihei, H | 2 |
| Sekine, S | 1 |
| Suganuma, S | 1 |
| Onuki, T | 1 |
| Uchida, K | 1 |
| Kawashima, A | 1 |
| Funabiki, K | 1 |
| Shirato, I | 1 |
| Koide, H | 2 |
| Ozaki, T | 1 |
| Nakayama, S | 1 |
| Barbara, JA | 1 |
| Thomas, AC | 1 |
| Smith, PS | 2 |
| Gillis, D | 1 |
| Ho, JO | 1 |
| Woodroffe, AJ | 2 |
| Matsuda, O | 1 |
| Makiguchi, K | 1 |
| Ishibashi, K | 1 |
| Chida, Y | 1 |
| Ida, T | 1 |
| Matsuda, K | 1 |
| Tomita, K | 1 |
| Marumo, F | 1 |
| Hiruma, M | 1 |
| Kato, A | 1 |
| Fujigaki, Y | 1 |
| Arai, T | 1 |
| Iketani, M | 1 |
| Moore, RH | 1 |
| Cunningham, J | 1 |
| Glassock, RJ | 1 |
| Cameron, JS | 1 |
| Healy, MJ | 1 |
| Chen, A | 1 |
| Ko, WS | 1 |
| Mavromatidis, C | 1 |
| Spaia, S | 1 |
| Christidou, F | 1 |
| Vayonas, G | 1 |
| Jones, B | 1 |
| Fowler, J | 1 |
| Ito, M | 1 |
| Aono, Y | 1 |
| Suzuki, A | 1 |
| Nagamatsu, T | 1 |
| Suzuki, Y | 1 |
| Turner, AN | 1 |
| Maidment, CG | 1 |
| Evans, DJ | 1 |
| Rees, AJ | 1 |
| Yamamoto, Y | 1 |
| Wakisaka, O | 1 |
| Miyata, J | 1 |
| Tanaka, K | 1 |
| Fushimi, T | 1 |
| Shearman, JD | 1 |
| Yin, ZG | 1 |
| Aarons, I | 1 |
| Clarkson, AR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy[NCT03018535] | Phase 3 | 76 participants (Actual) | Interventional | 2012-01-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for prednisolone and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Cronkhite-Canada Syndrome Associated with Gastric Outlet Obstruction and Membranous Nephropathy: A Case Report and Review of the Literature.
Topics: Gastric Outlet Obstruction; Glomerulonephritis, Membranous; Humans; Intestinal Polyposis; Male; Midd | 2020 |
Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Biopsy; Castleman Disease; Drug | 2021 |
Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review.
Topics: Adult; Blood Component Removal; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Lipoprotei | 2022 |
Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature.
Topics: Aged; Anti-Inflammatory Agents; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Fluoren | 2017 |
Membranous nephropathy and Kimura's disease manifesting a hip mass. A case report with literature review.
Topics: Adolescent; Angiolymphoid Hyperplasia with Eosinophilia; Diagnosis, Differential; Glomerulonephritis | 2010 |
[Membranous nephropathy].
Topics: Angiotensin-Converting Enzyme Inhibitors; Autoantibodies; Complement Activation; Complement Membrane | 2010 |
[Treatment and prognosis of idiopathic membranous nephropathy in guidelines for nephrotic syndrome].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Drug The | 2011 |
[Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan].
Topics: Blood Component Removal; Cause of Death; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; D | 2002 |
[Refractory nephrotic syndrome].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Biomarkers; Blood Component Removal; Drug | 2004 |
[Nephrotic syndrome].
Topics: Albumins; Animals; Diet, Sodium-Restricted; Dietary Proteins; Diuretics; Edema; Furosemide; Glomerul | 2005 |
Medical decision-making in membranous nephropathy: how to use limited clinical research evidence in patient management.
Topics: Adult; Aged; Chlorambucil; Cyclophosphamide; Decision Trees; Evidence-Based Medicine; Glomerulonephr | 2005 |
Retroperitoneal fibrosis associated with membranous nephropathy effectively treated with steroids.
Topics: Aged; Anti-Inflammatory Agents; Glomerulonephritis, Membranous; Humans; Male; Prednisolone; Recurren | 2002 |
Long-term effects of steroid treatment on nephrotic syndrome associated with Kimura's disease and a review of the literature.
Topics: Aged; Angiolymphoid Hyperplasia with Eosinophilia; Biopsy; Glomerulonephritis, Membranous; Humans; K | 1992 |
The therapy of idiopathic membranous glomerulonephritis.
Topics: Alkylating Agents; Antineoplastic Agents; Glomerulonephritis, Membranous; Humans; Prednisolone; Pred | 1991 |
20 trials available for prednisolone and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, Membra | 2014 |
Patient age and the prognosis of idiopathic membranous nephropathy.
Topics: Age Factors; Aged; Aging; Anti-Inflammatory Agents; Cyclosporine; Follow-Up Studies; Glomerulonephri | 2014 |
Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.
Topics: Adult; Azathioprine; Creatinine; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Im | 2009 |
Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Topics: Adult; Aged; Cost-Benefit Analysis; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Im | 2010 |
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
Topics: Chlorambucil; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Glomerular Filt | 2013 |
The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Topics: Biopsy; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, Membranous | 2004 |
[Clinical outcome assessment of membranous nephropathy].
Topics: Adult; Aged; Anti-Inflammatory Agents; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Hu | 2005 |
Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Topics: Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppr | 2006 |
A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
Topics: Adult; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Glomerulonephritis, Membr | 2007 |
Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclophosphamide; Dose-Response Relation | 2008 |
Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Mycophen | 2007 |
Treatment of idiopathic membranous nephropathy.
Topics: Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Kidney Function Tests; Prednisolone; Prog | 1994 |
Treatment of idiopathic membranous nephropathy.
Topics: Azathioprine; Creatinine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Prednis | 1994 |
Prognosis and management of membraneous nephropathy.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Sch | 1993 |
Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis.
Topics: Adult; Aged; Chlorambucil; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans | 1994 |
Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; | 1994 |
Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
Topics: Adolescent; Adult; Aged; Azathioprine; Disease Progression; Female; Glomerulonephritis, Membranous; | 1998 |
[Assessment of adrenal function on steroid using renal diseases in children using the modified original ACTH tolerance test: comparing nephrotic syndrome with non-nephrotic syndrome].
Topics: Adolescent; Adrenal Cortex; Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Anti-Inflamm | 1999 |
The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party.
Topics: Adult; Double-Blind Method; Drug Administration Schedule; Female; Glomerulonephritis, Membranous; Hu | 1990 |
Immunosuppression for membranous nephropathy.
Topics: Adult; Chlorambucil; Clinical Trials as Topic; Drug Administration Schedule; Follow-Up Studies; Glom | 1988 |
97 other studies available for prednisolone and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous nephropathy.
Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Infant; Male; Nephro | 2023 |
An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous nephropathy.
Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Infant; Male; Nephro | 2023 |
An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous nephropathy.
Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Infant; Male; Nephro | 2023 |
An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous nephropathy.
Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Infant; Male; Nephro | 2023 |
Complete remission of primary membranous nephropathy following hepatitis E infection.
Topics: Acute Disease; Adult; Glomerulonephritis, Membranous; Hepatitis E; Humans; Male; Middle Aged; Nephro | 2023 |
Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records.
Topics: Demography; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Japan; Neph | 2023 |
A case of idiopathic membranous nephropathy and psoriasis vulgaris.
Topics: Cyclophosphamide; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Etanercep | 2022 |
Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Glomerulonephritis, Membranous; Glucocort | 2017 |
Outcome of Idiopathic Membranous Nephropathy: A Retrospective Study.
Topics: Adult; Biopsy; Cyclophosphamide; Disease Progression; Female; Follow-Up Studies; Glomerular Filtrati | 2018 |
A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis.
Topics: Anti-Inflammatory Agents; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Im | 2018 |
Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Topics: Aged; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunosuppressive | 2018 |
VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases.
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Biomarkers; Biopsy, Needle; Female; Follow-Up St | 2019 |
Falsely elevated plasma ACTH levels measured by the Elecsys assay related to heterophilic antibody in a case of secondary adrenocortical insufficiency.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Biological Assay; Female; Glomerulonephritis, Me | 2019 |
Membranous nephropathy caused by rheumatoid arthritis.
Topics: Anti-Citrullinated Protein Antibodies; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Female; Glom | 2019 |
ACP Journal Club. Prednisolone plus chlorambucil preserved renal function in membranous nephropathy.
Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Predni | 2013 |
Immunosuppression for membranous nephropathy.
Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Predni | 2013 |
Immunosuppression for membranous nephropathy.
Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Predni | 2013 |
Immunosuppression for membranous nephropathy.
Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Predni | 2013 |
Immunosuppression for membranous nephropathy.
Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Predni | 2013 |
Immunosuppression for membranous nephropathy.
Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Predni | 2013 |
Immunosuppression for membranous nephropathy - Authors' reply.
Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Predni | 2013 |
Tonsillar Kaposi sarcoma in a patient with membranous glomerulonephritis on immunosuppressive therapy.
Topics: Adult; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunocompromised Host; Immunosuppressi | 2013 |
Membranous nephropathy with crescents in a patient with Hashimoto's thyroiditis: a case report.
Topics: Adult; Azathioprine; Cyclophosphamide; Glomerulonephritis; Glomerulonephritis, Membranous; Hashimoto | 2014 |
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studi | 2015 |
Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine.
Topics: Aged; Anti-Inflammatory Agents; Creatinine; Drug Therapy, Combination; Female; Glomerulonephritis, M | 2015 |
A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis.
Topics: Administration, Oral; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Glomerulone | 2015 |
Post-Transplant Membranous Nephropathy Associated with Chronic Active Antibody-Mediated Rejection and Hepatitis C Infection after Deceased Donor Renal Transplantation.
Topics: Female; Glomerulonephritis, Membranous; Graft Rejection; Hepatitis C; Histocompatibility Antigens Cl | 2016 |
Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.
Topics: Adolescent; Adult; Calcineurin Inhibitors; Cyclophosphamide; Drug Resistance; Drug Therapy, Combinat | 2016 |
Case of generalised myasthenia gravis with membranous nephropathy.
Topics: Adult; Blepharoptosis; Female; Glomerulonephritis, Membranous; Humans; Kidney Failure, Chronic; Myas | 2008 |
Rasmussen syndrome combined with IgA deficiency and membranous nephropathy.
Topics: Adrenocorticotropic Hormone; Brain; Child; Encephalitis; Glomerulonephritis, Membranous; Humans; IgA | 2009 |
Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Glucocorticoids; | 2009 |
An unusual case of loin pain and nephritis.
Topics: Adolescent; Cyclosporine; DNA; Enoxaparin; Female; Glomerulonephritis, Membranous; Humans; Immunosup | 2010 |
Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases.
Topics: Aged; Female; Glomerulonephritis, Membranous; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hu | 2011 |
[Case of MPO-ANCA-associated vasculitis with membranous nephropathy].
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis, Membra | 2011 |
Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Emtricitabine | 2011 |
Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Biopsy; Cyclosporine; Dose-Respons | 2011 |
Combined administration of low-dose prednisolone and cyclosporine in idiopathic membranous nephropathy: Tsukuba's regimen for IMN.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 2012 |
De novo postallogeneic hematopoietic stem cell transplant membranous nephropathy.
Topics: Glomerulonephritis, Membranous; Glucocorticoids; Hematopoietic Stem Cell Transplantation; Humans; Le | 2013 |
Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?
Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Creatinine; Cyclosporine; D | 2012 |
Idiopathic membranous nephropathy: back to the future?
Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Predni | 2013 |
A difficult trade off for adults with membranous nephropathy.
Topics: Adult; Chlorambucil; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Immunosuppre | 2013 |
[Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy].
Topics: Adult; Female; Glomerulonephritis, Membranous; Humans; Interferon beta-1b; Interferon-beta; Kidney; | 2013 |
[Quadritherapy with cyclosporine for membranous lupus nephropathy].
Topics: Adult; Angiotensin Receptor Antagonists; Cyclosporine; Drug Administration Schedule; Drug Therapy, C | 2003 |
Nephrotic syndrome caused by membranous nephropathy: response to a short course of cyclophosphamide alternating with prednisolone.
Topics: Biopsy, Needle; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administrat | 2004 |
Cyclosporin A-induced remission of primary membranous glomerulonephritis in a child.
Topics: Child, Preschool; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; I | 2004 |
Nephrotic syndrome after stem cell transplantation.
Topics: Adult; Cyclosporine; Fatal Outcome; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressiv | 2005 |
Distribution of IgG subclasses in a biopsy specimen showing membranous nephropathy with anti-glomerular basement membrane glomerulonephritis: an uncharacteristically good outcome with corticosteroid therapy.
Topics: Aged; Autoantibodies; Basement Membrane; Biopsy; Female; Glomerulonephritis, Membranous; Humans; Imm | 2005 |
[Changes in the clinical features of MPGN type-I in childhood over three decades].
Topics: Child; Drug Administration Schedule; Drug Therapy, Combination; Glomerulonephritis, Membranous; Hema | 2005 |
Hypovolemic shock as an initial presentation of pediatric systemic lupus erythematosus.
Topics: Adolescent; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Glomerulon | 2005 |
Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
Topics: Aged; Albumins; Alpha-Globulins; beta 2-Microglobulin; Cyclophosphamide; Follow-Up Studies; Glomerul | 2006 |
Systemic lupus erythematosus (SLE) presenting with nephrotic syndrome and membranous glomerulopathy in a 10-year-old girl.
Topics: Antibodies, Antinuclear; Biopsy, Needle; Child; Cyclophosphamide; Diagnosis, Differential; Drug Ther | 2005 |
Crescentic transformation of membranous glomerulopathy: a reversible condition.
Topics: Administration, Oral; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; | 2006 |
Coexistence of idiopathic membranous glomerulonephritis and idiopathic focal segmental glomerulosclerosis.
Topics: Biopsy; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis, Membranous; Glomerulosclero | 2005 |
[Three patients with nephrotic syndrome due to membranous nephropathy complicated by Sjögren's syndrome].
Topics: Adult; Anti-Inflammatory Agents; Female; Glomerulonephritis, Membranous; Humans; Liver Cirrhosis, Bi | 2005 |
Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
Topics: Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerulonephritis, Membranou | 2006 |
Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Topics: Adult; Aged; Azathioprine; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomeru | 2006 |
[Advances in the treatment of adult nephrotic syndrome].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Glomerulonephri | 2007 |
Mesangiolytic glomerulopathy after radiotherapy and chemotherapy of gastric lymphoma.
Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Combined Mo | 2007 |
Correlation between histologic features and glomerular permeability in membranous nephropathy and immunoglobulin A nephropathy.
Topics: Adolescent; Adult; Aged; Dextrans; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Glom | 1994 |
Hepatitis B 's' and 'e' antigen carriage in childhood nephrotic syndrome predicts membranous glomerulonephritis.
Topics: Algorithms; Child; Child, Preschool; Diuretics; Female; Follow-Up Studies; Glomerulonephritis, Membr | 1993 |
Membranous nephropathy associated with psoriasis vulgaris.
Topics: Autoimmune Diseases; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Prednisolone; Psoria | 1994 |
Relationship between interstitial infiltrates and steroid responsiveness of proteinuria in membranous nephropathy.
Topics: Adult; Aged; Antibodies, Monoclonal; Biopsy; CD4-Positive T-Lymphocytes; Female; Glomerulonephritis, | 1994 |
Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.
Topics: Adult; Aged; Chlorambucil; Cohort Studies; Female; Glomerulonephritis, Membranous; Humans; Kidney; K | 1994 |
Membranous allograft nephropathy. Remission of nephrotic syndrome with pulsed methylprednisolone and high-dose alternate-day steroids.
Topics: Female; Glomerulonephritis, Membranous; Humans; Kidney Transplantation; Methylprednisolone; Middle A | 1993 |
Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy.
Topics: Adult; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulo | 1993 |
[Fatal case of Crow-Fukase syndrome with kidney failure, acute consciousness disorder and thrombocytopenia].
Topics: Acute Disease; Anti-Inflammatory Agents; Consciousness Disorders; Fatal Outcome; Glomerulonephritis, | 1995 |
Membranous glomerulonephropathy associated with psoriasis vulgaris.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Complement C3; Cyclophosphamide; Glomerulonephritis, | 1996 |
Membranous nephropathy associated with an inflammatory myelopathy.
Topics: Azathioprine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; | 1996 |
Membranous nephropathy complicating adenolymphoma of the parotid (Warthin's tumour).
Topics: Adenolymphoma; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Cyclophosphamide; | 1996 |
Relapsing membranous nephropathy with a good response to steroid therapy.
Topics: Adult; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Kidney; M | 1997 |
Treatment of progressive renal failure and nephrotic syndrome with azathioprine and prednisolone.
Topics: Anti-Inflammatory Agents; Azathioprine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Ag | 1997 |
[A case of hepatitis C virus associated membranous glomerulonephritis ameliorated by corticosteroid therapy].
Topics: Angiotensin-Converting Enzyme Inhibitors; Enalapril; Glomerulonephritis, Membranous; Glucocorticoids | 1998 |
Appearance of nephrotic syndrome following interferon-alpha therapy in a patient with hepatitis B virus and hepatitis C virus coinfection.
Topics: Anti-Inflammatory Agents; Female; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis C; Humans; | 1998 |
A case of membranous nephropathy associated with psoriasis vulgaris.
Topics: Albuminuria; Basement Membrane; Glomerulonephritis, Membranous; Humans; Kidney Glomerulus; Male; Mid | 1998 |
Treatment of progressive renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
Topics: Azathioprine; Disease Progression; Follow-Up Studies; Glomerulonephritis, Membranous; Glucocorticoid | 1998 |
Primary biliary cirrhosis associated with membranous glomerulonephritis.
Topics: Adult; Azathioprine; Biopsy; Cholagogues and Choleretics; Diagnosis, Differential; Dipyridamole; Dru | 1999 |
Nephrotic syndrome due to membranous glomerulonephritis in a patient with idiopathic thrombocytopenic purpura.
Topics: Adolescent; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Humans; Kidney; Nephrotic Synd | 1999 |
Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?
Topics: Adult; Aged; Azathioprine; Biopsy; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans | 1999 |
Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Female; Glomerulonep | 1999 |
Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
Topics: Adult; Chlorambucil; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1999 |
Sarcoidosis with membranous nephropathy and granulomatous interstitial nephritis.
Topics: Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Kidney; Lung; Middle Aged; Nephriti | 1999 |
Clinical features and treatment outcome of idiopathic membranous nephropathy in Chinese patients.
Topics: Aged; Antihypertensive Agents; Chlorambucil; Creatinine; Cyclophosphamide; Drug Therapy, Combination | 1999 |
A case of anti-glomerular basement membrane glomerulonephritis superimposed on membranous nephropathy.
Topics: Anti-Glomerular Basement Membrane Disease; Female; Glomerulonephritis, Membranous; Humans; Immunosup | 2000 |
Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form.
Topics: Adult; Cyclosporine; Glomerulonephritis; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis B vi | 2000 |
Membranoproliferative glomerulonephritis associated with hypocomplementemic urticarial vasculitis after complete remission of membranous nephropathy.
Topics: Anti-Inflammatory Agents; Complement System Proteins; Glomerulonephritis, Membranoproliferative; Glo | 2001 |
[Effect of cyclosporin A on renal function in patients with glomerulonephritis].
Topics: Adult; Blood Pressure; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerula | 2001 |
[An elderly case of ANCA-positive membranous nephropathy].
Topics: Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Arthritis, Rheumatoid; Female; Glom | 2002 |
Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dipyridamole; Drug Therapy, Combin | 1992 |
Two-color analysis of lymphocyte subpopulations in patients with nephrotic syndrome due to membranous nephropathy.
Topics: Adult; Cell Separation; Female; Flow Cytometry; Glomerulonephritis, Membranous; Humans; Male; Nephro | 1992 |
Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
Topics: Adult; Antibodies, Antinuclear; Biopsy; Bone Marrow Transplantation; Cyclosporine; Fluorescent Antib | 1992 |
[A case of IGA nephropathy complicated with membranous nephropathy].
Topics: Adult; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Immunoglobulin A; Immunoglob | 1991 |
Crescentic transformation in primary membranous glomerulonephritis.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Kidney; | 1991 |
Horseshoe kidney and membranous glomerulonephropathy.
Topics: Adult; Glomerulonephritis, Membranous; Humans; Kidney; Male; Prednisolone | 1990 |
Treatment of membranous nephropathy with prednisolone and chlorambucil.
Topics: Adrenal Insufficiency; Chlorambucil; Drug Therapy, Combination; Glomerulonephritis, Membranous; Huma | 1989 |
Membranous nephropathy associated with sarcoidosis. Response to prednisolone.
Topics: Adult; Female; Glomerulonephritis, Membranous; Humans; Prednisolone; Sarcoidosis | 1989 |
Accelerated passive Heymann nephritis in rats as an experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis.
Topics: Animals; Azathioprine; Disease Models, Animal; Glomerulonephritis; Glomerulonephritis, Membranous; K | 1989 |
Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function.
Topics: Adult; Chlorambucil; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Glome | 1988 |
[Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Humans; Male; M | 1988 |
[Effects of alternate-day therapy with prednisolone in idiopathic membraneous nephropathy].
Topics: Adult; Aged; Drug Administration Schedule; Female; Glomerulonephritis, Membranous; Humans; Male; Mid | 1988 |
The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
Topics: Adolescent; Adult; Aged; Biopsy; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; | 1988 |